Tone mix
Week by week 52 weeks
Share of Revolution Medicines, Inc. Common Stock's 280 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Apr 27, 2026 · tone -74Revolution Medicines and the RAS Resistance Problem: Nicholas Hornstein Sees a Different Playbook-116
- Week of Nov 10, 2025 · tone -50Revolution Medicines Posts Wider-Than-Expected Loss in Q3, Sales Nil-99
- Week of Oct 5, 2026 · tone -37Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines' Daraxonrasib-92
- Week of Feb 9, 2026 · tone +99Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $78.94 Average PT from Analysts+82
- Week of Jan 26, 2026 · tone -49Revolution Medicines Shares Slide 17%-65
- Week of Jun 29, 2026 · tone -24Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd.-63
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Revolution Medicines, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 4 | +45 |
| Last 30 sessions | 23 | +51 |
| Last 90 sessions | 98 | +50 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.fool.com · 1 outletRevolution Medicines (RVMD) Q3 2026 Earnings Call TranscriptNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Revolution Medicines (RVMD) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletRevolution Medicines (RVMDW) Projected to Post Quarterly Earnings on WednesdayNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Revolution Medicines (RVMDW) Projected to Post Quarterly Earnings on Wednesday | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
1 headline, average tone +81: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.prnewswire.com · 3 outletsMedicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award"Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Medicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award" | www.prnewswire.com | 3 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 29, 2026
1 headline, average tone +99: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.fool.com · 1 outletCould Revolution Medicines Be a Millionaire-Maker Stock?Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Could Revolution Medicines Be a Millionaire-Maker Stock? | www.fool.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
2 headlines, average tone +48: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.fool.com · 3 outletsBillionaire Stanley Druckenmiller Added to Revolution Medicines Before Its FDA Win. Is the Stock Still a Buy After a 134% Run?Positive
- 247wallst.com · 1 outletRevolution Medicines (RVMD) Stock Price, News & AnalysisNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Billionaire Stanley Druckenmiller Added to Revolution Medicines Before Its FDA Win. Is the Stock Still a Buy After a 134% Run? | www.fool.com | 3 | Positive |
| Revolution Medicines (RVMD) Stock Price, News & Analysis | 247wallst.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Revolution Medicines, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.